David Abram Zisman, MD, MS | |
2950 Cleveland Clinic Blvd Bldg A, Weston, FL 33331-3625 | |
(818) 825-5654 | |
Not Available |
Full Name | David Abram Zisman |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 33 Years |
Location | 2950 Cleveland Clinic Blvd Bldg A, Weston, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558381699 | NPI | - | NPPES |
00C512790 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | ME154855 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vitas Healthcare Corporation Of Florida | Melbourne, FL | Hospice |
Cleveland Clinic Hospital | Weston, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Florida A Nonprofit Corporation | 7911807128 | 618 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
A consortium of scientists from across the country has found that breathing ultrafine particles from a large family of materials that increasingly are found in a host of household and commercial products, from sunscreens to the ink in copy machines to super-strong but lightweight sporting equipment, can cause lung inflammation and damage.
› Verified 6 days ago
Entity Name | Cleveland Clinic Florida A Nonprofit Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
A consortium of scientists from across the country has found that breathing ultrafine particles from a large family of materials that increasingly are found in a host of household and commercial products, from sunscreens to the ink in copy machines to super-strong but lightweight sporting equipment, can cause lung inflammation and damage.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
David Abram Zisman, MD, MS 2950 Cleveland Clinic Blvd Bldg A, Weston, FL 33331-3625 Ph: (818) 825-5654 | David Abram Zisman, MD, MS 2950 Cleveland Clinic Blvd Bldg A, Weston, FL 33331-3625 Ph: (818) 825-5654 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
A consortium of scientists from across the country has found that breathing ultrafine particles from a large family of materials that increasingly are found in a host of household and commercial products, from sunscreens to the ink in copy machines to super-strong but lightweight sporting equipment, can cause lung inflammation and damage.
› Verified 6 days ago
Dr. Chirayu Trivedi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3250 Meridian Pkwy, Weston, FL 33331 Phone: 954-659-5867 Fax: 954-659-5354 | |
Manju R Morrissey, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2200 N Commerce Pkwy, Weston, FL 33326 Phone: 954-331-3545 | |
Vineeth Mohan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 Fax: 954-659-6039 | |
Sarah Abbas, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-6161 Fax: 954-659-5425 | |
Dr. Saad Majzoub Sabbagh, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-6161 | |
Radhika Salwan, DO, MS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 | |
Dr. Stephen Garrett Marcus, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1792 Bell Tower Ln, Weston, FL 33326 Phone: 954-315-3660 Fax: 954-315-3661 |